舒华体育品牌怎么样 申请店铺

我要投票 舒华体育在仰卧板行业中的票数:881 更新时间:2026-01-12
舒华体育是哪个国家的品牌?「舒华体育」是 舒华体育股份有限公司 旗下著名品牌。该品牌发源于福建,由创始人张维建在1996-10-10期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力舒华体育品牌出海!将品牌入驻外推网,定制舒华体育品牌推广信息,可以显著提高舒华体育产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

舒华体育怎么样

舒华体育,专业、科学的运动健康解决方案提供商,以“产品智能化、运动科学化”为发展思路,推行多品牌战略,旗下拥有舒华(SHUA)和伯康(BANCON)两大品牌,提供多元化健身器材产品,是行业内产业链颇为完整的企业之一。产品涵盖家庭健身器材、商用健身器材、全民健身器材、理疗养护器材、健身小件及商业空间道具等产品,并通过舒华运动健康学院输出科学运动干预方案,为用户提供专业、科学的健身解决方案、产品和服务,让简单运动融入每个人的生活,帮助人们构建健康生活方式,从而实现健康目标,推动社会更加美好。

舒华于1996年,成立于中国体育产业基地晋江,迄今已分别在福建晋江、泉州台商投资区以及河南商丘共拥有三个生产基地,在全国范围内拥有上千家售服网点,并建立了线上线下O2O售服一体化渠道。同时,舒华逐步推行品牌国际化战略,全球业务涉及欧美、中东、东南亚等80多个国家和地区。

多年来,舒华与中国健美协会、北京体育大学、成都体育学院等研究机构及多位著名专家合作,共同研发产品和运动处方,拥有专利技术104项。2016年,舒华成立了运动健康学院,为用户提供运动能力评估、运动健康课程、专业系统运动健康管理等服务。经过20多年的发展,舒华已从“健身器材生产和销售企业”逐步升级为“专业、科学的运动健康解决方案提供商”。一直以来,舒华肩负“健康中国”发展使命,致力于推动全民健身事业和体育事业的发展。

未来,舒华将一如既往地秉承“诚信•拼搏•创新•共享”的核心价值观,坚持为用户提供更高品质的产品、更完善的服务、更科学的健身指导,推进舒华品牌国际化进程!


Shuhua sports, a professional and scientific sports health solution provider, takes "intelligent products and scientific sports" as the development idea and carries out the multi brand strategy. Its two brands, Shua and Bancon, provide diversified fitness equipment products. It is one of the enterprises with complete industrial chain in the industry. The products cover family fitness equipment, commercial fitness equipment, national fitness equipment, physical therapy and maintenance equipment, fitness pieces and commercial space props, etc., and output scientific exercise intervention programs through Shuhua sports and health college to provide users with professional and scientific fitness solutions, products and services, so that simple sports can be integrated into everyone's life and help people build healthy students Lifestyle, so as to achieve health goals and promote a better society. Shuhua was founded in 1996 in Jinjiang, China's sports industry base. So far, it has three production bases in Jinjiang, Fujian, Quanzhou, Taiwan business investment zone and Henan Shangqiu, with thousands of sales and service outlets nationwide, and has established an online and offline o2o sales and service integration channel. At the same time, Shuhua has gradually implemented the brand internationalization strategy, and its global business covers more than 80 countries and regions, including Europe, the United States, the Middle East and Southeast Asia. Over the years, Shuhua has cooperated with research institutions such as China Bodybuilding Association, Beijing Sport University, Chengdu Sport Institute and many famous experts to jointly develop products and sports prescriptions, with 104 patented technologies. In 2016, Shuhua established the school of sports and health to provide users with sports ability assessment, sports and health courses, professional system sports and health management services. After more than 20 years of development, Shuhua has gradually upgraded from a "fitness equipment production and sales enterprise" to a "professional and scientific sports health solution provider". All along, Shuhua shoulders the development mission of "healthy China" and is committed to promoting the development of national fitness and sports. In the future, Shuhua will, as always, adhere to the core values of "integrity, hard work, innovation and sharing", adhere to providing users with higher quality products, better services, more scientific fitness guidance, and promote the internationalization process of Shuhua brand!

本文链接: https://brand.waitui.com/3ea077035.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

快手-W获南向资金净买入22.45亿港元

南向资金今日净买入73.06亿港元,快手-W、腾讯控股、南方恒生科技净买入额位列前三,分别获净买入22.45亿港元、20.12亿港元、8.58亿港元。净卖出方面,中国移动、美团-W、中国平安分别遭净卖出10.30亿港元、4.82亿港元、3.42亿港元。(第一财经)

50分钟前

世茂能源:筹划控制权变更事项,股票继续停牌

36氪获悉,世茂能源公告,公司控股股东世茂投资及实控人正在筹划公司股份转让事宜,该事项可能导致公司的控制权变更,公司股票已于1月12日开市起停牌,并将于1月13日继续停牌,预计停牌(累计)时间不超过2交易日。

50分钟前

华兰生物:参股公司药品注册申请获受理

36氪获悉,华兰生物公告,公司参股公司华兰安康生物股份有限公司近日收到国家药监局签发的阿达木单抗注射液境内生产药品注册上市许可申请《受理通知书》。药品适应症为类风湿关节炎、强直性脊柱炎、银屑病、克罗恩病、葡萄膜炎、多关节型幼年特发性关节炎、儿童斑块状银屑病、儿童克罗恩病等多类免疫性疾病。

50分钟前

国药现代:注射用哌拉西林钠通过仿制药一致性评价

36氪获悉,国药现代公告,全资子公司国药集团威奇达药业有限公司收到国家药监局核准签发的《药品补充申请批准通知书》,批准注射用哌拉西林钠新增1.0g规格及本品0.5g、1.0g、2.0g通过仿制药质量和疗效一致性评价。

50分钟前

*ST大立:变更部分回购股份用途并注销

36氪获悉,*ST大立公告,公司董事会审议通过议案,同意公司对根据2022年回购方案已回购并存放于回购专用账户的剩余57.52万股股份的用途进行变更,由“用于对公司核心骨干员工实施股权激励或员工持股计划”变更为“用于注销并减少公司注册资本”,并将按规定办理回购股份注销暨减少公司注册资本手续。该议案尚需提交公司股东会审议。

50分钟前

本页详细列出关于舒华体育的品牌信息,含品牌所属公司介绍,舒华体育所处行业的品牌地位及优势。
咨询